219 related articles for article (PubMed ID: 34168096)
21. Colorectal Cancer that Highly Express Both
Wang H; Yang J
Pathol Oncol Res; 2021; 27():612969. PubMed ID: 34257580
[TBL] [Abstract][Full Text] [Related]
22. Neuropilin-1-Mediated SARS-CoV-2 Infection in Bone Marrow-Derived Macrophages Inhibits Osteoclast Differentiation.
Gao J; Mei H; Sun J; Li H; Huang Y; Tang Y; Duan L; Liu D; Pang Y; Wang Q; Gao Y; Song K; Zhao J; Zhang C; Liu J
Adv Biol (Weinh); 2022 May; 6(5):e2200007. PubMed ID: 35195371
[TBL] [Abstract][Full Text] [Related]
23. TMPRSS2, a SARS-CoV-2 internalization protease is downregulated in head and neck cancer patients.
Sacconi A; Donzelli S; Pulito C; Ferrero S; Spinella F; Morrone A; Rigoni M; Pimpinelli F; Ensoli F; Sanguineti G; Pellini R; Agrawal N; Izumchenko E; Ciliberto G; Giannì A; Muti P; Strano S; Blandino G
J Exp Clin Cancer Res; 2020 Sep; 39(1):200. PubMed ID: 32967703
[TBL] [Abstract][Full Text] [Related]
24. TOX correlates with prognosis, immune infiltration, and T cells exhaustion in lung adenocarcinoma.
Guo L; Li X; Liu R; Chen Y; Ren C; Du S
Cancer Med; 2020 Sep; 9(18):6694-6709. PubMed ID: 32700817
[TBL] [Abstract][Full Text] [Related]
25. Upregulation of ACE2 and TMPRSS2 by particulate matter and idiopathic pulmonary fibrosis: a potential role in severe COVID-19.
Li HH; Liu CC; Hsu TW; Lin JH; Hsu JW; Li AF; Yeh YC; Hung SC; Hsu HS
Part Fibre Toxicol; 2021 Mar; 18(1):11. PubMed ID: 33706759
[TBL] [Abstract][Full Text] [Related]
26. A Comprehensive Analysis of NRP1 in Malignancies Provide Therapeutic Implication for Treating Cancer Patients Infected with SARS-CoV-2.
Chen S; Zhang L; Song Y; Xie K; Wang Y; Liang Y
Biochem Genet; 2023 Nov; ():. PubMed ID: 37938510
[TBL] [Abstract][Full Text] [Related]
27. In Silico Identification of miRNA-lncRNA Interactions in Male Reproductive Disorder Associated with COVID-19 Infection.
Sabetian S; Castiglioni I; Jahromi BN; Mousavi P; Cava C
Cells; 2021 Jun; 10(6):. PubMed ID: 34204705
[TBL] [Abstract][Full Text] [Related]
28. Expression and co-expression analyses of TMPRSS2, a key element in COVID-19.
Piva F; Sabanovic B; Cecati M; Giulietti M
Eur J Clin Microbiol Infect Dis; 2021 Feb; 40(2):451-455. PubMed ID: 33245471
[TBL] [Abstract][Full Text] [Related]
29. The contrasting role of nasopharyngeal angiotensin converting enzyme 2 (ACE2) transcription in SARS-CoV-2 infection: A cross-sectional study of people tested for COVID-19 in British Columbia, Canada.
Nikiforuk AM; Kuchinski KS; Twa DDW; Lukac CD; Sbihi H; Basham CA; Steidl C; Prystajecky NA; Jassem AN; Krajden M; Patrick DM; Sekirov I
EBioMedicine; 2021 Apr; 66():103316. PubMed ID: 33819740
[TBL] [Abstract][Full Text] [Related]
30. Identification of a novel therapeutic candidate, NRK, in primary cancer-associated fibroblasts of lung adenocarcinoma microenvironment.
Wei T; Song J; Liang K; Li L; Mo X; Huang Z; Chen G; Mao N; Yang J
J Cancer Res Clin Oncol; 2021 Apr; 147(4):1049-1064. PubMed ID: 33387038
[TBL] [Abstract][Full Text] [Related]
31. Nasal expression of SARS-CoV-2 entry receptors in newborns.
Heinonen S; Helve O; Andersson S; Janér C; Süvari L; Kaskinen A
Arch Dis Child Fetal Neonatal Ed; 2022 Jan; 107(1):95-97. PubMed ID: 33990387
[TBL] [Abstract][Full Text] [Related]
32. Gene of the month:
Thunders M; Delahunt B
J Clin Pathol; 2020 Dec; 73(12):773-776. PubMed ID: 32873700
[TBL] [Abstract][Full Text] [Related]
33. Expression of ACE2 and TMPRSS2 Proteins in the Upper and Lower Aerodigestive Tracts of Rats: Implications on COVID 19 Infections.
Sato T; Ueha R; Goto T; Yamauchi A; Kondo K; Yamasoba T
Laryngoscope; 2021 Mar; 131(3):E932-E939. PubMed ID: 32940922
[TBL] [Abstract][Full Text] [Related]
34. ACE-2, TMPRSS2, and Neuropilin-1 Receptor Expression on Human Brain Astrocytes and Pericytes and SARS-CoV-2 Infection Kinetics.
Malik JR; Acharya A; Avedissian SN; Byrareddy SN; Fletcher CV; Podany AT; Dyavar SR
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239978
[TBL] [Abstract][Full Text] [Related]
35. Initial study on TMPRSS2 p.Val160Met genetic variant in COVID-19 patients.
Wulandari L; Hamidah B; Pakpahan C; Damayanti NS; Kurniati ND; Adiatmaja CO; Wigianita MR; Soedarsono ; Husada D; Tinduh D; Prakoeswa CRS; Endaryanto A; Puspaningsih NNT; Mori Y; Lusida MI; Shimizu K; Oceandy D
Hum Genomics; 2021 May; 15(1):29. PubMed ID: 34001248
[TBL] [Abstract][Full Text] [Related]
36. Expression profiling meta-analysis of ACE2 and TMPRSS2, the putative anti-inflammatory receptor and priming protease of SARS-CoV-2 in human cells, and identification of putative modulators.
Gkogkou E; Barnasas G; Vougas K; Trougakos IP
Redox Biol; 2020 Sep; 36():101615. PubMed ID: 32863223
[TBL] [Abstract][Full Text] [Related]
37. Ginsenosides, potential TMPRSS2 inhibitors, a trade-off between the therapeutic combination for anti-PD-1 immunotherapy and the treatment of COVID-19 infection of LUAD patients.
Meng M; Gao R; Liu Z; Liu F; Du S; Song Y; He J
Front Pharmacol; 2023; 14():1085509. PubMed ID: 36992839
[No Abstract] [Full Text] [Related]
38. Age-determined expression of priming protease TMPRSS2 and localization of SARS-CoV-2 in lung epithelium.
Schuler BA; Habermann AC; Plosa EJ; Taylor CJ; Jetter C; Negretti NM; Kapp ME; Benjamin JT; Gulleman P; Nichols DS; Braunstein LZ; Hackett A; Koval M; Guttentag SH; Blackwell TS; Webber SA; Banovich NE; ; ; Kropski JA; Sucre JM
J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33180746
[TBL] [Abstract][Full Text] [Related]
39. Network Pharmacology and Bioinformatics Analysis Identifies Potential Therapeutic Targets of Paxlovid Against LUAD/COVID-19.
Zhang W; Yang Z; Zhou F; Wei Y; Ma X
Front Endocrinol (Lausanne); 2022; 13():935906. PubMed ID: 36157452
[TBL] [Abstract][Full Text] [Related]
40. A meta-analysis of comorbidities in COVID-19: Which diseases increase the susceptibility of SARS-CoV-2 infection?
Singh MK; Mobeen A; Chandra A; Joshi S; Ramachandran S
Comput Biol Med; 2021 Mar; 130():104219. PubMed ID: 33486379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
